Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for EXELON
- Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h)
- Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)
- Rivastigmine Patch Compared to Melatonin Patch in Prevention of Postoperative Delirium
- Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)
- Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase
- A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
- Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD
- Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles
- 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
- Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease
- Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients
- Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
- Mild Cognitive Impairment in Parkinson's Disease
- A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
- Comparative Research of Alzheimer's Disease Drugs
- Cognitive Decline in Non-demented PD
- Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients
- Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients
- Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions
- Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions
- Rivastigmine as a Treatment for Methamphetamine Dependence
- A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
- Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
- Exelon Patch and Combination With Memantine Comparative Trial
- The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems
- Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
- Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial
- Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
- Rivastigmine for Intensive Care Unit (ICU) Delirium
- A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers
- Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
- Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy
- Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
- Treatment of Orthostatic Hypotension in Autonomic Failure
- Mifepristone as Adjunctive Therapy in Alzheimer's Disease
- Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease
- Lipitor as a Treatment for Alzheimer's Disease
- Electrophysiologic Measures of Treatment Response in Alzheimer Disease
- Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)
Clinical trials list
click for details